For example, studies have shown that the combination of TKIs with BCL6 and MCL1 inhibitors may lead to the complete eradication of CML stem cells (Madapura et al., 2017). Here, BCL6 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.